AstraZeneca (AZNN MM)

121

Analysis

Health Care • United Kingdom

AstraZeneca is a multinational pharmaceutical and biotechnology company that researches, develops, and manufactures prescription medicines. The company focuses on core therapeutic areas including oncology, cardiovascular, renal and metabolic diseases, respiratory and immunology, and rare diseases. It was founded in 1999 and is headquartered in Cambridge, UK.

Refresh

Exchange Announcement • 28 Feb 2026 05:05

424B2 | Prospectus

Exchange Announcement • 25 Feb 2026 21:30

424B2 | Prospectus

Exchange Announcement • 20 Mar 2024 05:27

DFAN14A | Definitive additional proxy soliciting materials filed by non-management

Exchange Announcement • 24 Feb 2024 05:09

424B2 | Prospectus

Exchange Announcement • 21 Feb 2024 21:13

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00